Rotateq Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Live, oral pentavalent rotavirus vaccine

Indications/Uses

Prevention of severe rotavirus gastroenteritis in infants & childn.

Dosage/Direction for Use

Vaccination series: 3 doses administered orally to infants. 1st dose should be administered at 6-12 wk of age; subsequent doses should be given at a min interval of 4 wk; 3rd dose should not be given after 32 wk of age.

Administration

May be taken with or without food: Gently squeeze liqd into infant's mouth toward the inner cheek until dosing tube is empty.

Contraindications

Hypersensitivity; individuals who develop symptoms suggestive of hypersensitivity after receiving a dose should not receive further doses. Postpone vaccination in subjects suffering from acute diarrhea or vomiting. Subjects w/ congenital malformations of GIT. Known or suspected immunodeficiency; not recommended to administer in asymptomatic HIV subjects. Severe combined immunodeficiency disease. Previous history of intussusception.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BH01 - rota virus, live attenuated ; Belongs to the class of rota virus diarrhea viral vaccines.

Regulatory Classification

POM

Presentation/Packing

Form

Rotateq oral soln 2 mL

Packing/Price

1's

Rotateq

rotavirus vaccine

Manufacturer:

MSD